Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25

Stephen Boorjian

Research output: Contribution to journalShort surveypeer-review

Fingerprint

Dive into the research topics of 'Commentary on "Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma." Choueiri TK, Lim ZD, Hirsch, MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM, Dana-Farber Cancer Institute, Boston, MA. Cancer 2010;116:5219-25'. Together they form a unique fingerprint.